Roche Diagnostics Says HPV, MRSA Molecular Tests Will Help Drive Near-Term Growth

The head of Roche Diagnostics today highlighted the company's PCR-based tests for human papillomavirus and methicillin-resistant Staphylococcus aureus as potential key drivers of expected continued growth in the coming year of the company's diagnostics business.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.